Drug Name: Ofatumumab
Drug Class: It is a chemotherapy/targeted therapy drug
Available under the brand names: Arzerra, Kesimpta
What Is It Prescribed For?
- Arzerra is approved for Chronic lymphocytic leukemia (a kind of white blood cell cancer)
- Kesimpta is approved for Relapsing multiple sclerosis (a disease of the brain and spinal cord)
How Is It Given?
Kesimpta is given subcutaneously(under the skin) and Arzerra is given intravenously (into a vein).
What Are Common Side Effects?
You may face some of these side effects:
- Injection-related reactions like nausea, vomiting, redness, difficulty breathing, fever, and chills
- Skin rashes
- Weakness
- Headache
- Diarrhea
- Cough
Your doctor can prescribe medication to control these side effects. Ofatumumab may also cause other side effects. If you face any unusual or serious problems, inform your doctor immediately.
Who Should Avoid Taking This Drug?
It should be avoided in patients with active Hepatitis-B virus (HBV) infection.
How Much Does This Drug Cost?
Available in 100mg and 1000mg. Depending on the brand, the cost of Ofatumumab 100mg can range between INR 48,000 – INR 52,000.
